Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Abroad (travel likely)RecruitingPHASE2
Conditions
Solid Tumor, Adult
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Samsung Medical Center, Seoul, South Korea
Study leads
Se-Hoon Lee, MD, PhD
Principal Investigator
Samsung Medical Center